RAnbaxy komal (1).docx

8/19/2019 RAnbaxy komal (1).docx

1/44

R A N B A X Y L A B O R A T O R I E S L I M I T E D P a g e | 1

A

Project ReportOn

Financial AnalysisOf

Submie! "

Global Institute of Management#u$a%a Tec&n"l"gical 'ni(e%siy

On)*+),+,*),

In Pa%ial ful-llmen "f &e %e.ui%emens f"% &eAcc"uning f"% Manage%s c"u%se in &e

Mase% "f Business A!minis%ai"n P%"g%amme

Submie! By/

0"mal Dulam 1)23R"na0 M"!i 1)43As&a Desai 1)53De(i0a Sing& 1)637eul Pael 1,*3

#LOBAL INSTIT'TE OF MANA#EMENT


2/44


Preface

T&e sub$ec mae% "f -nancial managemen &as been c&anging a a%a8i! 8&ase ab"u &%ee !eca!es ag"9 &e sc"8e "f -nancial managemen :asci%cumsc%ibe! " &e %aising "f fun!s; :&ene(e% nee!e! an! lile signi-cance use "aac& " &e -nancial !ecisi"n ma0ing "f 8%"blem s"l(ing &e mi! -fies; &eem8&asis s&ife! " :ise uilim"!e%n? &in0ing in &e -nancial managemen gi(es g%eae%im8"%ance "f managemen an! !ecisi"n ma0es 8"licy= T"!ay &e -nancial mg is n"

in a 8assi(e %"le "f a sc"%e0ee8e% "f &e acc"uning inf"%mai"n an! a%%anging fun!s=

@e as a su!en "f managemen cann" 0ee8 "u%sel(es is"lae! f%"m &is-el! "f -nancial managemen= @e nee! " 0n": &e 8%acical a88licai"n "f "% "&e%&e"%eical 0n":le!ge s" :e &a(e 8%e8a%e! a -nancial %e8"% "n RanbayLab"%a"%ies L!=C an! &a(e %ie! " analysis eac& an! e(e%y %e8"% "f annual %e8"% "f -(e successi(e yea%s an! 8u i in l"gical f"%ma as 8e% my analysis=



3/44


Acknowledgement

We are very much thankful to Ranbaxy laboratories Ltd. for these all type of informationis taken from the last five year financial statement.

We are also thankful to our Director Mr. Kishor Bhunsali who encourages us for studying the

finance.

We are mostly thankful to our Prof. Dhaval Patel for helping us in our practical studies in our

sem-1 !"#$ program and also very much thankful to her valuable suggestion% guidance in preparing this

report.

#lso thankful to our parents for providing oriented and for all encouragement.



4/44


Executive summary

&perating expenses may be defined as those that pertain to the production process% or% more

generally% the process of carrying out the business. 'uch processes include all those pertaining to purchases%

human resources% production and marketing and selling. (onventionally% expenses incurred on rising or

using finances are not considered as operational expenses. )here are a few more - amorti*ation% write-offs%

prior-period expenses% etc. &ften% the distinction between operating and non-operating expenses is clear. "ut

at times there is some ambiguity regarding the nature of the expense.

#s a result% the basic framework of data capture at (!+, avoids the classification of expense heads

as operational and non-operational. owever% disclosure practices of companies often compel us to use the

term operational expenses. ,xpenses that can be posted without the use of such a term are posted

appropriately into (!+,/s detailed classification of expense items and% the remaining operational expenses0

are clubbed into one of the two data-fields &ther operational expenses of industrial enterprises or &ther

operational expenses of non-financial services enterprises.

)his data-field includes all operating expenses of an industrial enterprise that are not already

covered in any of the other data field. )hese are likely to be industry-specific operational expenses.

,xamples of such expenses can be preservation expenses% laboratory expenses% testing expenses etc.

Index



5/44


r.!o. "ontent Page no.

1(hapter 1

+ntroduction of (ompany

2

3&a8e%,/

"m8a%ai(e Balance s&ee an! Analysis "f Balance S&ee4

5(hapter-5

(omparative 6rofit and Loss #ccount and #nalysis of 6rofit 7 Loss 'tatement

8(hapter-8

(ommon 'i*e 'tatements

2(hapter 2

)rend #nalysis +ndex #nalysis$

9(hapter 9

#nalysis of (ash flow 'tatement

4(hapter 4

Ratio #nalysis

:(hapter :

Recommendation 7 'uggestions

;(hapter ;

(ontemporary +ssues in #ccounting of the company



6/44


"#AP$E%& ' ("om)any )rofile*

'.' Introduction of "om)any

Ranbaxy was started by Ranbir 'ingh and oined the company in 1;94% the company saw a significant

transformation in its business and scale. is sons !alvinder !ohan 'ingh and 'hivinder !ohan 'ingh sold

the company to the =apanese company Daiichi 'ankyo in =une 3??:.

Ranbaxy was established in 1;91 and went public in the year 1;45. +t has global sales of @'A158? million for the year ended on 51st December% 3??9. +t has the largest market in @'# sales appx. @'

A5:? million$B then come ,urope and "R+(' "ra*il% Russia% +ndia% (hina% 'outh #frica$.

'.+"om)any Details&

)ype - 6ublic

Counded - 1;91

eaduarters-


7/44

R A N B A X Y L A B O R A T O R I E S L I M I T E D P a g e |

'./Products

@sing the finest R7D and !anufacturing facilities% Ranbaxy Laboratories Limited manufactures

and markets generic pharmaceuticals% value added generic pharmaceuticals% branded generics% active

6harmaceuticals #6+$ and intermediates.

)he (ompany remains focused on ascending the value chain in the marketing of pharmaceutical

substances and are determined to bring in increased revenues from dosage forms sales.

Ranbaxy/s diverse product basket of over 2%??? 'I@s available in over 132 countries worldwide

encompasses a wide therapeutic mix covering a ma>ority of the chronic and acute segments. ealthcare

trends pro>ect that the chronic treatment segments will outpace the acute treatment segments% primarily

driven by a growing aging population and dominance of lifestyle diseases. )heir robust performance in(ardiovasculars% (entral Gervous 'ystem% Respiratory% Dermatology% &rthopedics% Gutritionals and @rology

segments% clearly indicates that the (ompany has strengthened its presence in the fast-growing chronic and

lifestyle disease segments.

• $o) '0 Molecules (+0'+*

J Ealacyclovir

J 'imvastatin

J Donepe*il

J #torvastatin 7 (ombinationsJ (o-amoxyclav 7 (ombinations

J (iprofloxacin 7 (ombinations

J Ietorolac )romethamine

J +mipenemK(ilastatin

J


8/44

R A N B A X Y L A B O R A T O R I E S L I M I T E D P a g e | !

• '.1 "om)any #istory&

Ranbaxy Laboratories Ltd. is the largest pharmaceutical company in +ndia% and one of theworld/s top 1?? pharmaceutical companies. Long a specialist in the preparation of generic drugs%

Ranbaxy is also one of the world/s top 1? in that pharmaceutical category as well. et% with +ndia/s

agreement to apply international patent law at the beginning of 3??2% Ranbaxy has begun converting

itself into a full-fledged research-based pharmaceutical company.

# ma>or part of this effort has been the establishment of the company/s own research and

development center% which has enabled the company to begin to enter the new chemical entities G(,$

and novel drug delivery systems GDD'$ markets. +n the mid-3???s% the company had a number of

G(,s in progress% and had already launched its first GDD' product% a single daily dosage formulation

of ciprofloxacin.

Ranbaxy is a truly global operation% producing its pharmaceutical preparations in

manufacturing facilities in seven countries% supported by sales and marketing subsidiaries in 88

countries% reaching more than 1?? countries throughout the world. )he @nited 'tates% which alone

accounts for nearly half of all pharmaceutical sales in the world% is the company/s largest international

market% representing more than 8? percent of group sales. +n ,urope% the company/s purchase of R6<

#ventis$ '.#. makes it the largest generics producer in that market.

)he company is also a leading generics producer in the @nited Iingdom and or markets include "ra*il% Russia% and (hina% as well as +ndia% which together added 39 percent to

the group/s sales. Ranbaxy posted revenues of A1.1: billion in 3??8. )he company% which remains

controlled and led by the founding 'ingh family% is listed on the Gational 'tock ,xchange of +ndia in

!umbai.



9/44

R A N B A X Y L A B O R A T O R I E S L I M I T E D P a g e | "

• '.2 Board of Directors

#t the helm of the entire operations is the experience and able direction of the people who make it allhappen. Ranbaxy acknowledges their inspiring stewardship and indefatigable work.

Dr. $sutomu 3ne

(hairman Gon ,xecutive 7

Gon +ndependent Director

Mr. Arun awhney

(,& 7 !anaging DirectorMr. $akashi hoda

Gon ,xecutive 7 Gon +ndependent Director

Dr. Ka4unori #irokawa

Gon ,xecutive 7 Gon +ndependent Director

Dr. Anthony #. 5ild

+ndependent DirectorMr. %a6esh 7. hah

+ndependent Director

Mr. Akihiro 5atana8e

+ndependent DirectorMr. Percy K. hroff

+ndependent Director


http://www.ranbaxy.com/aboutus/Team_DispNew_.aspx?id=69&flag=http://www.ranbaxy.com/aboutus/Team_DispNew_.aspx?id=69&flag=http://www.ranbaxy.com/aboutus/Team_DispNew_.aspx?id=77&flag=http://www.ranbaxy.com/aboutus/Team_DispNew_.aspx?id=77&flag=http://www.ranbaxy.com/aboutus/Team_DispNew_.aspx?id=68&flag=http://www.ranbaxy.com/aboutus/Team_DispNew_.aspx?id=68&flag=http://www.ranbaxy.com/aboutus/Team_DispNew_.aspx?id=89&flag=http://www.ranbaxy.com/aboutus/Team_DispNew_.aspx?id=89&flag=http://www.ranbaxy.com/aboutus/Team_DispNew_.aspx?id=70&flag=http://www.ranbaxy.com/aboutus/Team_DispNew_.aspx?id=70&flag=http://www.ranbaxy.com/aboutus/Team_DispNew_.aspx?id=71&flag=http://www.ranbaxy.com/aboutus/Team_DispNew_.aspx?id=71&flag=http://www.ranbaxy.com/aboutus/Team_DispNew_.aspx?id=72&flag=http://www.ranbaxy.com/aboutus/Team_DispNew_.aspx?id=72&flag=http://www.ranbaxy.com/aboutus/Team_DispNew_.aspx?id=74&flag=http://www.ranbaxy.com/aboutus/Team_DispNew_.aspx?id=74&flag=http://www.ranbaxy.com/aboutus/Team_DispNew_.aspx?id=69&flag=http://www.ranbaxy.com/aboutus/Team_DispNew_.aspx?id=77&flag=http://www.ranbaxy.com/aboutus/Team_DispNew_.aspx?id=68&flag=http://www.ranbaxy.com/aboutus/Team_DispNew_.aspx?id=89&flag=http://www.ranbaxy.com/aboutus/Team_DispNew_.aspx?id=70&flag=http://www.ranbaxy.com/aboutus/Team_DispNew_.aspx?id=71&flag=http://www.ranbaxy.com/aboutus/Team_DispNew_.aspx?id=72&flag=http://www.ranbaxy.com/aboutus/Team_DispNew_.aspx?id=74&flag=


10/44

R A N B A X Y L A B O R A T O R I E S L I M I T E D P a g e | 1#

"#AP$E%& + (Balance sheet +009:+0'+*

Balance S&ee "f Ranbay Lab"%a"%ies "f ,**4,*))

$$$$$$$$$$$$$$$$$$ in Rs% &r% $$$$$$$$$$$$$$$$$$$

Particular

s'ec (11 'ec (1# 'ec (#" 'ec (#! 'ec (#

)ources Of *un+s T"al S&a%e

a8ial,))=** ,)*=, ,)*=,) ,)*=)6 )52=G

E.uiy

S&a%e

a8ial

,))=** ,)*=, ,)*=,) ,)*=)6 )52=G

S&a%e

A88licai"n

M"ney

*=24 2=2* )4=5 )4=22 )=)5

P%efe%ence

S&a%e

a8ial

*=** *=** *=** *=** *=**

Rese%(es );4)H=)2 G;6)=,5 H;4G5=G H;HH*=6, ,;H*=25

Re(aluai"n Rese%(es

*=** *=** *=** *=** *=**

,et -ort. 1/"24%!3 5/132%4# 4/134%6# 3/16% 2/53!%4#Secu%e!

L"ans,,6=6 )6=H6 )4=5H )2,=*4 H2=*4

'nsecu%e!

L"ansG;)*H=6G G;*2=HH H;)4,= H;2H=H* H;)H4=62

T"al Deb G;HHH=H G;,2*=4, H;HG5=H5 H;4,=H4 H;*H=*H

0otaliabilities

6/25!%36 "/3"3%12 /4!2%"! /442%14 6/#41%43



11/44


Application Of *un+s

#%"ss

Bl"c0H;*6G=*4 ,;54=2H ,;2,*=6, ,;H52=4 ,;,2)=G5

Less/

Accum=

De8%eciai"

n

);,,,=*4 );)G=, );*,4=, 6H*=*4 46)=62

,et loc 1/!2%## 1/12%11 1/5"3%4# 1/456%6! 1/46"%52a8ial

@"%0 in

P%"g%ess

,,,=2, HH*=)5 G)G=6, G,5=44 H,4=G,

Inestme

nts 3/41#%" 3/!#4%44 3/!33%6" 3/61!%#3 3/23%55In(en"%ies );2=,H );G56=6) );,H*=G5 );)65=, 642=*4Sun!%y

Deb"%sH;256=6 );,6,=2H );HG=2 );*,G=G 55,=6)

as& an!

Ban0

Balance

22=6* ,,=GG ,=2 G6=52 26=H5

0otal

&urrentAssets

5/412%#! 2/!#4%"! 2/"#%6" 2/22%"2 1/"2!%36

L"ans an!

A!(ances,;H5,=4, );G4*=G );624=2 ,;H)=65 55,=66

Fie!

De8"sis);54)=)G ,;256=5 4,5=2 );55=*5 )))=*4

T"al A;

L"ans

A!(ances

6;22=6G 2;62=,5 ;G52=6* 2;*6=65 ,;6,,=G,

Defe%%e!

%e!i*=** *=** *=** *=** *=**

u%%en

Liabiliies;)4=25 ,;G6)=*5 H;*5,=56 H;5G*=)) );)44=H

P%"(isi"ns H;4=H) 6,4=5, 42H=*H 4H)=,* 4H5=)G T"al L

P%"(isi"ns5;6),=66 H;G)5=6* H;5G=6, G;4)=H) );6)=G6

,et

&urrent

Assets

52%"5 3/546%3! 1/64#%"! 1/"3!%6 1/##6%"3

Miscellane *=** *=** *=** *=** *=**#LOBAL INSTIT'TE OF MANA#EMENT


12/44


"us

E8enses0otal

Assets6/25!%36 "/3"3%11 /4!2%"" /442%15 6/#41%42

&omparatie alance s.eet of Ranba aboratories"f 2##$2#11

$$$$$$$$$$$$$$$$$$ in Rs% &r% $$$$$$$$$$$$$$$$$$$

Particular

s

'ec

(11$

1#

'ec

(1#$

#"

'ec

(#"$

#!

'ec

(#!$

#

7

(11$

1#

7

(1#$

#"

7

(#"$

#!

7

(#!$

#)ources Of *un+s

T"al S&a%e

a8ial*=G5 *=H) *=*, ,H=2

*=,,5

**4

*=)G4

G4,

*=**6

)

),=24

5,E.uiy

S&a%e

a8ial

*=G5 *=H) *=*, ,H=2*=,,5

**4

*=)G4

G4,

*=**6

)

),=24

5,

S&a%e

A88licai"n

M"ney

=6H

)26=,

*=)6)4G=G

5

56=5G

5

62=,G

25

*=)*5

)2H

)G452

=GG

P%efe%ence

S&a%e



13/44


a8ial

Rese%(es

H,*

,=),

))22=

4G

G)4=2

,

65*=,

G

2=)G

2,

H)=),

)5

),=H

425

G)=4*

*,4

Re(aluai"nRese%(es

,et -ort.

H,*

4=4

664=5G)4=5

H

))45=

H4

2,=G6

2

,G=)H

,6H

))=,G

)4

G2=G,

)42

Secu%e!

L"ansHG=, )6=2 )H=42 ,*H

)4=*

HG

))=),

GH5

5=G6*

)6

=2*

5

'nsecu%e!L"ans

H5=2)

56,=45

H6*=4

G,=HG

*=6G64H5

,5=)G*44

)*=62

2

)H=G24

T"al Deb4,=5

)

6),=H

G

H42=6

6

,,,=H

G

)=4*5

522

,4=,G

4,)

)*=))

6

2=HG4

*44

0otal

iabilities

$

313

4%

6

1"1#

%14

4#%!

4

14##

%1

$

33%3

2"

25%52

646

#%54!

6

23%1!

5#


#%"ss Bl"c0,H2=

GG

,H2=4

)

,HG=)

4

),=,

45=,4 6=*H 6=5) =G

Less/

Accum=

De8%eciai"

n

42=

))5=*

*64=G

)H5=)

)2=25 ))=G5 )*=G5 )4=GG

,et loc )6=56

))5=4)

)H2=4,

),=5G

6=HG 4=G 6=H6 *=54

a8ial

@"%0 in

P%"g%ess

)*4=

2

5G=4G

)H=5

)*)=H

H,=5 ,*=G, H=,H H*=6

Inestmen

ts

H6H=

2

,6=,

,)=2

2

H5*=G

5)*=H *=42 =62 ))=4

In(en"%ies )2=H,

,6=GH

H)=62 ,,,=G

))=)* ,)=*5 ,=24 ,,=46

Sun!%y ,;H6 )*=) )G)=2 )5=G )=44 G6=46 )2=*G



14/44


Deb"%s 4=H,,G,=*

,) H 2

as& an!

Ban0

Balance

GG=G

2H=),

,G=H*

)6=,

)65=)

H),=,) G5=4G ,5=)H

0otal

&urrent

Assets

,;2*

4=)*)G=,6

)4=4

4

HGG=

26,=6 *=) ,,=45 )4=54

L"ans an!

A!(ances

6),=

,4

G64=,

*

H5G=H

H

);G25

=662,=*G ,=,4 )2=HG

)22=H

4

Fie!

De8"sis

5)5=

4)

);62)

=,6

);)2

=,

);44G

=*)H*=GG

,26=,

*2)=H

);64=

,*

T"al A;

L"ans

A!(ances

,;4*

*=22

);G45

=H5

);*,H

=*5

H;54

=2H5=44 ,2=6G )=4,

),,=4

2

Defe%%e!

%e!i

u%%en

Liabiliies

,;22

2=2*

6)=5

)

44=,

,

,;22,

=42

)*4=*

)6=,* )6=4,,,2=)

4

P%"(isi"ns,;5,

4=G6

)2G=4

6H)=5H 2=6G

H*G=4

,)=2* G=H *=6G

T"al L

P%"(isi"ns

;G6

G=*6

G,4=*

,

4,=H

6

,;2

=5,

)2*=4

*))=)* )=54

)H5=2

,et

&urrent

Assets

,;46

H=GH

);6*

=G*

,64=2

6

6H)=4

G45=44

))2=)

))=H2 6,=H

Miscellane"

us

E8enses

s

0otal

Assets

H;)H

G=4

);6)*

=),G*=5G

);G**

=4HHH=H4 ,=H *= ,H=)6

Inter)retation

T"al "f &e s&a%e&"l!e% fun!s an! liabiliies inc%ease c"ninu"usly in ,**6 ",*)) because "f g%":& "f &e c"m8any=



15/44


T"al liabiliies &a(e been inc%easing ill ,*))=

u%%en liabiliies &a(e als" been inc%ease! in ,*))=

T&e "al asses als" inc%ease yea% :&ic& s&":s &a c"m8anyPu%c&ases in(esmens an! asses e(e%y yea%=

Is s&":s c"m8any?s g""! 8%"-abiliy an! -nancial s"un!ness=

T&e Ne Bl"c0 "f a c"m8any :as c"ninu"usly inc%ease! f"% bu in ,*)* i :as!ec%ease!=

"#AP$E%& / (Profit and ;oss account +00


16/44


Profit and ;oss Account of %an8axy la8.

Particulars 'ec (11 'ec (1# 'ec (#" 'ec (#! 'ec (#IncomeSales

Tu%n"(e% 4;4*6=)4 ;254=HH G;464=G6 G;242=,) G;HGG=H6Ecise Duy ,,=5 G*=62 )=6* ,G=)4 )=H4Ne Sales 4;252=6 ;2G2=H4 G;45)=6 G;2,=*G G;,6H=*,

O&e% Inc"me

H;66*=42,=G G5=22 );54=2G )=)H

S"c0

A!$usmens)H=4, )2)=GH HH=62 ))=6 G*=22

0otal

Income

3/!31%

46/3#%25 5/3#1%21 3/1"%"" 4/!!4%!1

8pen+itureRa:

Mae%ials,;,H=*5 ,;)5)=,, );6)2=5 ,;*G6=H* );52)=)4

P":e% Fuel

"s)6G=65 )H,=4 )*6=4 )*5=5H 6*=H

Em8l"yee

"s5G=,G 2*5=,5 5,=* G4,=2 G,*=*G

O&e%

Manufacu%in

g E8enses

)),=26 62=25 56=6G 6G=2 5,=2*

Selling an!

A!min

E8enses

);46=H4 );HH,=4* );H*2=, );G*,=44 );HG)=*H

Miscellane"u

s E8enses);,5H=G )5=)G )5=*4 H5H=,2 ),H=6*

P%e"8e%ai(e

E8a8iali


17/44


De8%eciai"n ,4G=*5 ,,5=H )G5=,* )G=G4 ))5=4HO&e% @%ien

OJ 4=5H *=** *=** *=** *=**

P%"- Bef"%e

Ta

H;*5=)

);*=6G 6*=2H );2H)=44 4H=2

E%a

"%!ina%y

iems

)=GG ,)=55 )))=G, )4=42 H=G2

PBT 1P"s

E%a"%!

Iems3

H;*GH=*4);4,=5, );*2,=* );2)G=*) 456=*,

Ta 2=26 G)=G5 G55=52 4G=,G )2=26

Reporte+,et Pro9t

$

3/#52%#

5

1/14!%3 51%"! $1/#44%!# 61%2

T"al Kalue

A!!ii"nG;*)=5, ,;H= ,;,G2=HH ,;G2,=)2 ,;*4=6H

P%efe%ence

Di(i!en!*=** *=** *=** *=** *=**

E.uiy

Di(i!en!*=*4 5G=,) *=** *=** H)4=)

"%8"%aeDi(i!en! Ta

*=H, )H=66 *=** *=** H=6*

S&a%es in

issue 1la0&s3G;,,*=** G;,)*=G) G;,*G=)4 G;,*H=4* H;4H*=4)

8arnings

Per ).are

:Rs;

$2%32 2%2! 13%61 $24%!5 16%56

E.uiy

Di(i!en! 13

*=*H G*=** *=** *=** )4*=**



18/44

R A N B A X Y L A B O R A T O R I E S L I M I T E D P a g e | 1!

&omparatie Pro9t an+ loss account of Ranba lt+% 2##$2#11

$$$$$$$$$$$$$$$$$$ in Rs% &r% $$$$$$$$$$$$$$$$$$$

Particular

s

'ec

(11$

1#

'ec

(1#$

#"

'ec

(#"$

#!

'ec

(#!$

#

7

(11$

1#

7

(1#$

#"

7

(#"$

#!

7

(#!$

#

IncomeSales

Tu%n"(e%

,;*,)=

5G556=5G ),)=,5 HH)=5, H= )5= ,=6 4=2G

Ecise Duy )5=H5 ,=*2 5=,4 ,4=,* GG=54 )4=2) HG=,, ,=6

Ne Sales,;*G*=

,,52G=45 ),6= H6=*, H2=)H )5=*6 ,=45 5=H2

O&e%

Inc"me

G;H=

*,

42=46,;*4H=

H*

,;)H5=

44

5*6=*)=5)

)H*=6

H55=*4

S"c0A!$usmen

s

,=4) ),4=G4 5)=2H 4G=6H )=6H H4=H 4*=2, )5G=,5

0otal

Income

,;H5=

)

);*26=

*G

,;),)=

,,

);4*G=

5,

H6=5 ,*=)4 22=4) HG=6*

8pen+itu

reRa:

Mae%ials HG)=52 ,2G=2G

)H,=4, )55=)H )=24 )H=5) 2=G5 )*=))

P":e%

Fuel "s2,=,H ,H=)5 *=4G )5=G5 G2=55 ,)=)2 *=25 ,*=G



19/44

R A N B A X Y L A B O R A T O R I E S L I M I T E D P a g e | 1"

Em8l"yee

"s,H2=62 ,=45 )*6=5 ,=2) H5=62 G=GH ,H=,G ),=,

O&e%

Manufacu%i

ngE8enses

)2=*) 2=4G G=4) ),=* )2=2 4=G6 G=65 )G=6

Selling an!

A!min

E8enses

,G2=24 ,2=G 62=, 2)=4G )5=) ,=*, 2=55 G=2*

Miscellane"

us

E8enses

);*65=

G*,4=*4

,,=)6,6=H2 6H=,5 )4=)H 5=42 ,*6=HH

P%e"8e%ai(

e E8

a8iali


20/44


Reporte+

,et Pro9t

G;,**=

45

42=4);2)2=

45

);22,=

,

H2=26)**=5H

)G=4

,26=)G

T"al Kalue

A!!ii"n

);22*=

,4)*6=,,

,)=5HG*G=,H 4*=G5 G=52 5=44 )6=2G

P%efe%ence

Di(i!en!*=** *=** *=** *=**

E.uiy

Di(i!en!5G=)G 5G=,) *=**

H)4=)66=6,

)**=**

"%8"%ae

Di(i!en!

Ta

)G=H) )H=66 *=** H=6*

)*,=,6

)**=**

S&a%es in

issue1la0&s3

6=6 2=,G *=G4 G4,=66 *=,H *=) *=*) ),=25

8arnings

Per ).are

:Rs;

66=2* )H=24 H5=G2 G)=G)

H2=)*)**=GG

)G=44

,*=*2

E.uiy

Di(i!en!

13

H6=64 G*=** *=**

)4*=**66=6H

)**=**

Inter)retation

)otal income is more than total expenditure in every year.

Get profit has been increased in 3?11 around 93?M.

+n 3?11 the earning per share shows in negative change. +t represent losses% non beneficial to the

company.

"#AP$E%&1 "ommon si4e tatement of %an8axy ltd.



21/44


Balance S&ee "f Ranbay Lab"%a"%ies "f ,**4,*))

$$$$$$$$$$$$$$$$$$ in Rs% &r% $$$$$$$$$$$$$$$$$$$



22/44


Pa%icula%s Dec )) Dec )* Dec *6 Dec *5 Dec *4

)ources Of *un+s T"al S&a%e

a8ial

H=H4)G6 ,=,G),) ,=5*6)4 ,=5,GH,, H=*5425

E.uiy

S&a%e

a8ial

H=H4)G6 ,=,G),) ,=5*6)4 ,=5,GH,, H=*5425

S&a%e

A88licai"n

M"ney

*=*)*4*2 *=*4*,2G ,=HG66662 ,=H2*HGH *=*)6H,

P%efe%ence

S&a%e

a8ial

* * * * *

Rese%(es ,4=H4H6G ,=H,5) *=*6G,)G GG=442 H5=6*6HHRe(aluai"

n Rese%(es* * * * *

,et -ort. H*=42)G G=2H666 =,HH55 G6=6G,,, G,=*)2GSecu%e!

L"ansH=225HH ,=*5*)G ,=HG64H,H ,=)444HG 2=*G,44

'nsecu%e!

L"ans2=4HH GH=,4654 G,=H62546 G4=55** )=6G*25

T"al Deb 26=,GH52 G=H2**) GG=4G22), *=*445 4=65HG20otal

iabilities)** )** )** )** )**


#%"ss

Bl"c0G6=GH566 H*=G,,2, H=*,*H4 H,=*4*4) H4=GH,6,

Less/

Accum=

De8%eciai"

n

)6=,4 ),=)6H, )H=4H)G) ),=G64HH )H=)*55G

,et loc ,6=6))66 )5=,,4H ,)=,6H2,4 )6=4HH5 ,G=H,G*5a8ial

@"%0 in

P%"g%ess

H=4)2, H=))H =GG5G,G =42)H4H =G)654

Inestme

nts G=G664G G*=*,G )=,H,*2) G5=2)H6 H=56,,In(en"%ies ,2=GG5H )=52)4H )2=GGH26G )2=)*GG6 )2=)2H



23/44


Sun!%y

Deb"%s5=62*HH )H=42)G4 ,*=*5)H )H=4224, )G=2)G,5

as& an!

Ban0

Balance

)=*2564 *=,H5566 *=HG)4G4 *=226625 )=)G5G*2

0otal

&urrent

Assets

52=G442) ,6=52,) H4=,6H45, H*=G))4 H)=6)566

L"ans an!

A!(ancesH5=*4,6 )=2G2 ,2=,6G64 H)=2*H )G=2)2

Fie!

De8"sis,6=565, ,5=2H2G, 6=4H2,)) ,=H,645 )=5H5G4

T"al A;

L"ans

A!(ances

)G=GG5G 4G=)H*5 4H=H,G625 54=G4GG G5=H4H*2

Defe%%e!

%e!i* * * * *

u%%en

Liabiliies5,=G),2G ,2=,*,6 G)=)652H6 )=66G4 )6=G5464

P%"(isi"ns 2*=**G4 6=544222 )*=)6252 6=5,))5 ),=,)466 T"al L

P%"(isi"ns )G,=G)4H H2=H6462 )=H6G65 2)=G,G6 H)=4*62,et

&urrent

Assets

),=*H))) H4=4), ,)=6,6G26 ,2=*G652 )2=224))

Miscellane

"us

E8enses

* * * * *

0otal

Assets

)** )** )** )** )**



24/44


Pro9t an+ loss account :common si


25/44


Operating

Pro9t)2=2 ,,=H )H=2* =G5 6=GH)),

PBDIT H=), H,=,G ,H=4H ,5=G4 ,,=,,6)HIne%es *=6* *=6 *=5, H=), ,=)*6

PBDT H2=*, H)=,6 ,,=6* H)=6 ,*=*45GDe8%eciai"n H=2 G=*, H=*6 H=H* ,=4H,6O&e% @%ien

OJ *=)* *=** *=** *=** *

P%"- Bef"%e

TaH6=24 ,4=,4 )6=5, HG=6* )4=HG6

E%a

"%!ina%y

iems

*=,* *=H5 ,=H, *=H5 *=5)2,,

PBT 1P"sE%a%"!

Iems3

H6=G4 ,4=2 ,,=)G HG=, )5=)2)5)

Ta *=*6 4=H) )*=)6 ),=,5 H=2*24,Reporte+

,et Pro9tH6=6 ,*=,* ))=6, ,,=HG )G=,)55

T"al Kalue

A!!ii"n,=*6 G)=G, G2=5, ,=2 G4=H265H

P%efe%enceDi(i!en!

*=** *=** *=** *=** *

E.uiy

Di(i!en!*=** )=G5 *=** *=** 4=H**,)6

"%8"%ae

Di(i!en! Ta*=** *=, *=** *=** )=,G*25)

S&a%es in

issue 1la&s3G=4G 4G=*H 54=2H 56=6* 5=54G,

8arnings

Per ).are

:Rs;

*=6G *=G5 *=,5 *=H *=H5))5)

E.uiy

Di(i!en! 13*=** *=4* *=** *=** H=6)H*6H

Analysis of "ommon i4e tatement

T&e c"n%ibui"n "f ne sales in "al inc"me :as nea%ly same in all &e yea%I :as nea% ab"u 65 " )**=



26/44


T&e c"n%ibui"n "f "al e8en!iu%e :as c"ninu"us !ec%ease yea% by yea%; buin ,*)) iInc%ease!=

S" &a f%"m &e ab"(e c"mm"n si


27/44


G4 ,H HH H4

T"al Deb )**)*2=HG

4)6=5

,),)=2,

62),H=4*

5

T"al Liabiliies )**),H=)5

)),H=52

)))=G4

5G)*H=6

*4

Application Of*un+s #%"ss Bl"c0

)**)*=H

6H))=56

G),2=H2

)))H2=5)

2,Less/ Accum=De8%eciai"n )**

))4=GH6

),6=4GH6

)GG=2GH4

)G=H*62

,et loc 1##

""%12625

1#!%43

116%5#!1

12%3!!5

a8ial @"%0 inP%"g%ess )**

)H*=6G)

),2=4,G)

)**=5GH

24=66,)5

In(esmens

)**

)))=4

,)

))5=G)

HH

))4=*

65

)*=H

)In(en"%ies

)**),,=46

*G),2=*2

G4),=2G

H5)26=5

))Sun!%y Deb"%s

)**))2=*G

)H)4H=5)

4H)G2=G*

2G)4=6H

*as& an! Ban0Balance )**

4)=52*6

H2=5G*6

H,=HGH2)

62=G,G5

T"al u%%enAsses )**

))4=525

)GG=4)5H

)G=G6G

,5*=24)

L"ans an!

A!(ances )**

,22=H2

G

,,,=5H

6G

)22=H

*5

,26=5G

25Fie! De8"sis

)** )264=,2=6G

24,G,)=4

2))25G=2

G6 T"al A; L"ans A!(ances )**

,,,=466

)54=4)6

,H5=HH6

HH*=4),

DiJe%e! %e!i u%%en Liabiliies

)**H,2=)2

,2)=5G

66,))=5

H2GH5=*4

HP%"(isi"ns

)**66=*6

5)*H=H4

,),=26

4*5=4

H)

T"al L P%"(isi"ns )** ,H5=2G62 ,**=45 )45=G54 G2=H)),Ne u%%en Asses

)**)6,=H

,4)2,=62

52H,=)6

4H4G=442

5Miscellane"usE8enses

0otal Assets 1##123%1

!54123%!

614155%4

!51#3%5

"#""ningenLiabiliies )**

),=462

),6=542

)H4=H45) )G5=*)

B""0 Kalue 1Rs3 )**

),H=52

G)

)H5=G

*,

)46=**

H)

24=*G5

62Inter)retation



28/44


Get worth was rapidly increasing from last 5 years but it has decreased in 3?11.

Get block of the balance sheet has been increasing from 3??: to 3?11 rapidly.

)otal assests was decreased in 3?11.

Pro9t an+ loss account :0ren+ analsis;

Income 2## 2##! 2##" 2#1# 2#11Sales

Tu%n"(e%)**

)*4=2H46

))*=G,6

)H*=6),)44=G))

Ecise Duy)**

G4=**5)

H*=6)6,

46=4H,

GH=62,

Ne Sales)**

)*5=H2,6

)))=H5*2

)H)=,GG

)46=*G5

O&e%Inc"me

)**,55=*4

55=),*44

)*,=*G4,G=*4)

S"c0A!$usmens

)**,5G=,5GH

5H=,)56

H64=*,G)

HHH=46,G

0otalIncome

1##65%#""56

1#!%5244

13#%4#"4

!%441"5

8pen+iture

Ra:

Mae%ials )**

))*=)*

5,

)*,=644

,

))4=)62

,

)H=2G

,P":e% Fuel "s

)**),*=GH5

),)=,4,5

)G2=6,52

,)=5*,

Em8l"yee"s

)**)),=,

)H5=244H

)GG=5)G5

,*)=,,5

O&e%Manufacu%ing E8enses

)**))G=55G

)*5=552,

))4=*G2)H2=G,52

Selling an!A!min

E8enses

)**)*G=2*H6

64=G*2G4

66=H455G

))4=44,6

Miscellane"us E8enses

)**H*6=HH*)

),4=454

)G6=G,4)*H=6G5

P%e"8e%ai(eE8

a8iali


29/44


Ine%es)**

)2=*5G5

G,=,GH

5=***2G

4G=H,H*,

PBDT)**

)26=H6

),=64*4

,*H=646,

H)5=H),

De8%eciai"n )**

)H*=)*)6 ),G=5,)

)6,=H,4)

,H*=5GH)

Ot.er=ritten

O>

P%"- Bef"%e Ta )**

,)2=G)

),2=))6

,*=5))

G*=54

E%a"%!ina%y

iems)**

*=*5G2

H)G=,)H,

2)=4*HHH

GH=G,*,

PBT 1P"sE%a"%!

Iems3)**

,*G=6

)HG=2*H4

)66=HH5G

H5=244

Ta)**

H22=G5,

H))=66)5

,2=)2*

G=,2644

Re8"%e!Ne P%"- )**

)26=)H5

6,=6H

)5=62,6

G6G=*5H

0otal ?alue

A++ition

1##11"%64

26

1#"%154

!

114%462

1

1"5%1

3!!Preference'ii+en+

E.uiyDi(i!en!

)** * * ,2=,)*=*,,*4,

"%8"%aeDi(i!en!

Ta)** * *

,=6G4

*=6H26

Per s.are+ata

:annuali


30/44


Inter)retation

)otal income of the company is decreased in 3?11 as compared to last four years.

,xpenditure is increased in 3?11% which is loss for a company.

,arnings per share were increasing till 3?1?% but it went to negative in 3?11.

&@AP08R 6 :&as.Bo- )tatement;

"ash ,low of %an8axy ;a8oratoriesin %s. "r.

Particulars. 'ec

(11

'ec

(1#

'ec

(#"'ec (#! 'ec (#

,et Pro9t efore 0a

$

3#4!%6

1565%

25

1#61%

"2

$

161"%#

!

4%41

Ne as& F%"m O8e%aing Aci(iies )H5=)G ))25=

56

22=GH

66=,, 25=44

Ne as& 1use! in3+f%"m

In(esing Aci(iies

)*6G=4

H

,*24=

5*

52=), G2,=6) 4*5=)5

Ne as& 1use! in3+f%"m Financing

Aci(iies

),25=6

5

66)=G

5

,)G=)G,5)4=,* )H,=)6

,et :+ecrease;Cincrease In &as.

an+ &as. 8Duialents$35%13 "2%5

$

"3%4

6

155%#

1#"%!

O8ening as& as& E.ui(alens )2)=5H 26=,2 52,=H6 )4,=)G 2,=H2

l"sing as& as& E.ui(alens ),2=4*)2)=5

H

25=6H )6,4=,) )4,=)G



31/44


Inter)retation

+t shows the cash inflow and outflow of the company.

)he highest cash euivalents in the year 3??: in last five years.

)here is a ma>or difference between the financing activities of the year

3??4 7 3??: because of company issue shares more than last year

(ash generated from operating activities is also highest in the 3?1? as compare

to the last five years. +t may be because of high collection of debtors or sales of goods and services.

+t shows from the last five year analysis that cash flow is in increasing and decreasing mood.

"ha)ter = (%atio analysis*

=.': ";AI,I"A$I! , %A$I

#s per reuirement of various users the ratio may be classified in following groups.

•• 6rofitability Ratio-6rofitability Ratio-

1.


32/44


•• Liuidity ratio-Liuidity ratio-

1. (urrent ratio3. Liuid ratio

•• Leverage ratio-Leverage ratio-

1. Debt euity ratio3. 6roprietary ratio5. (apital gearing ratio8. Long term fund to fixed assets

•• #ctivity ratio-#ctivity ratio-

1.1. 'ales turnover ratio

3.3. )otal assets turnover ratio

5.5. Debtor ratio

8.8. (reditor ratio

2.2. "ook value per share9.9. Working capital turnover ratio

• (overage ratio-(overage ratio-

1. 1. Debt service coverage ratio 3. +nterest coverage ratio

Profita8ility ratio

'.


33/44


,**4 ,**5 ,**6 ,*)* ,*))

*

)*

,*

H*

G*

*

2*

G*=)H

*=,

G=2H)=*G ,=*2

Gross pro9t

P%"-

Inter)retation& 6rofit is increased in 3??; because of more production. +t is in 3??4 is very less as

compare to other.

+. !et )rofit ratio N Get profit P1??

'ales 'ales

ear 3??4 3??: 3??; 3?1? 3?11

Get profit 1%:43.?? 1%413.11 1%2;5.8? 1%829.9: 1%89;.23

'ales 4%4?;.14 2%9:4.55 8%4;4.8; 8%949.31 8%588.5;

6rofit

marginM 38.3:3: 5?.1?5; 55.3153 51.12?; 55.:324



34/44


,**4 ,**5 ,**6 ,*)* ,*))

*

)*

)

,*

,

H*

H

G*

,G=,5

H*=)

HH=,)H)=)

HH=5H

,et pro9t

8%"-

Interpretation Ne 8%"- is inc%ease! in &e ,*)) by HH=5H :&ile

i is less in &e

,**4 by ,G=,5= I because "f inc%easing in m"%e selling "f 8%"!ucs=

5. &perating ratio N &perating exps P1??Sales

ears 3??4 3??: 3??; 3?1? 3?11s

&perating exps 9%25:.;? 8%259.44 8%193.;1 8%211.89 5%;1;.?;

'ales 4%4?;.14 2%9:4.55 8%4;4.8; 8%949.31 8%588.5;

&perating ratioM :8.:3 4;.44 :9.44 ;9.8: ;?.31



35/44


,**4 ,**5 ,**6 ,*)* ,*))

*

,*

G*

2*

5*

)**

),*

5G=5,46=44

52=44

62=G56*=,)

Operating ratio

O8e%aing %ai"

Inter)retation +n the ratio exps is ;9.8:M in the 3?1? it decrease the profit of the company.

8. ,arnings per share N ,arning per share O1?? 'hare holders fund

ears 3??4 3??: 3??; 3?1? 3?11

,arnings per

share-43.53 34.3: 15.91 -38.:2 19.29

'hare

holders fund1%;38.:5 2%153.8? 8%158.9? 5%419.44 3%25:.8?

,.6.' ratio -5.49 ?.25 ?.53; -?.94 ?.92

2. Return on capital employs Ratio N ,.".+.) P1??

Get worth



36/44


3??4 3??: 3??; 3?1? 3?11

,.".+.) -5%?2:.21 1%22?.;8 ;2?.95 -1%951.44 425.29 Get worth 1%;38.:5 2%153.8? 8%158.9? 5%419.44 3%25:.8?Return on

capitalemploys

ratio

12:.;? 5?.33 33.;; 85.;? 3;.9;

9. Dividend per share N euity dividend P1?? 6ref% share

Yea%s ,**4 ,**5 ,**6 ,*)* ,*))euity dividend *=*4 5G=,) *=** *=** H)4=)

6ref% share ,))=** ,)*=, ,)*=,) ,)*=)6 )52=GDi(i!en!

%ai"

*=*HH G* * * )4*=*)4s

•• Liuidity ratio-Liuidity ratio-

1. (urrent ratio N (urrent #ssets (urrent liabilities

ears 3??4 3??: 3??; 3?1? 3?11

(urrent assests 2%813.?: 3%:?8.;: 3%4;?.9; 3%343.;3 1%;3:.59

(urrent

liabilities

;)4=25 ,;G6)=*5 H;*5,=56 H;5G*=)) );)44=H

Ratio 1.?2 1.15 ?.;? ?.2; 1.98



37/44


,**4 ,**5 ,**6 ,*)* ,*))

*

*=,

*=G

*=2

*=5

)

)=,

)=G

)=2

)=5

)=*)=)H

*=6

*=6

)=2G

&urrent ratio

u%%en %ai"

Inter)retation ration is increased by 1.?2 in the 3??4 while it is 1.98 in last year so it is good for company

3. Liuid ratio N (urrent assests Fstock-prepared exps$.

(urrent liabilities.

Yea%s ,**4 ,**5 ,**6 ,*)* ,*))

(urrent

assests F

stock-

prepared

;,42=H2 ,;2GH= ,;42=4H ,;)4=HH );554=4*



38/44


exps$.

(urrent

liabilities. ;)4=25 ,;G6)=*5 H;*5,=56 H;5G*=)) );)44=H

Rai" )=*,H )=*2 *=56 *=2 )=2*

,**4 ,**5 ,**6 ,*)* ,*))

*

*=,

*=G

*=2

*=5

)

)=,

)=G)=2

)=5

)=*, )=*2

*=56

*=2

)=2

iDui+ ratio

Li.ui %ai"

Ine%8%eai"n/ In &e yea% ,*)) i is )=2 s" %e!uces &e

liabiliies=

•• Leverage ratio-Leverage ratio-

1. Debt euity ratio N Long term debt

S&a%e &"l!e%s fun!

ear 3??4 3??: 3??; 3?1? 3?11

Long term debt G;HHH=H G;,2*=4, H;HG5=H5 H;4,=H4 H;*H=*H



39/44


S&a%e

&"l!e%s fun!);6,G=5H ;)H,=G* G;)HG=2* H;4)2=44 ,;H5=G*

Ratio 3.32 ?.:5 ?.:1 1.?? 1.5:

,**4 ,**5 ,**6 ,*)* ,*))

*

*=

)

)=

,

,=,=,

*=5H *=5)

)

)=H5

'ebt ratio

!eb %ai"

Inter)retation +n the year 3??4 it is 3.32 while it is1.5: in the 3?11.

3. 6roprietary ratioN 'hare holders fund

)otal assets

ears 3??4 3??: 3??; 3?1? 3?11'hare

holders);6,G=5H ;)H,=G* G;)HG=2* H;4)2=44 ,;H5=

G*



40/44


fund

)otal

assets 2;,5=H2 6;H6H=)) 4;G5,=66 4;GG,=)2;*G)=

G,

Ratio ?.51 ?.22 ?.22 ?.2? ?.83

,**4 ,**5 ,**6 ,*)* ,*))

*

*=)

*=,

*=H

*=G

*=

*=2

*=H)

*= *=

*=

*=G,

Proprietar ratio

P%"8%iea%y %ai"

Interpretation In t.e 2##! E 2##" it is #%55 -.ile it is in t.e 2##

b #%31%

A""3!$I> P;I"E A!D !$E



41/44


ignificant accounting )olices&:

chedule ?!@&:

a. Basis )re)aration of financial statement&:

)he financial statement are prepared under the historical cost conventional accept for certain

fixed assets which are revalued in accordance with the generally accepted accounting

principles in +ndia. #nd the provisions of the companies act 1;29.8. 3se of estimates &:

)he preparation of financial statements reuires estimates and assumptions to be made that

affect the reported amount of assets and liabilities on the date of the financial statements and

the reported amount of revenues and expense during the accounting period.c. wn fixes assts&:

Cixed assets are stated at cost net of value added tax. #nd includes amounts added on

revaluations less accumulated depreciation and impairment loss if any all cost including

financial cost in commencement of commercial product net charges on foreign exchangecontract arising from exchange rate variations attribute table to the fixed assets are

capitali*ed.

d. ;eased assts&:

&perating leases rentals are expensed with reference to lease terms and other considerations.

+. finance leases prior to 1st #pril% 3??1 rentals are expensed with reference to lease terms and other

consideration.

++. Cinancial leases on or after 1st #pril. 3??1 the lower of the value of the assets and present value of the

minimum lease rentals is capitali*ed as fixed assets with corresponding amount shown as lease liability. )he

principal component in the lease rental is ad>usted against the lease liability and the interest component is

charged to profit and loss account.

e. Intangi8le assets&:

+ntangible assets are stated at cost of acuisition less accumulated amortiosation.f. De)reciation&:

Depreciation on fixes assets is provided to the extent of depreciable amount on written down

value method at rates and in the manner prescribed in the companyQs act 1;29.Depreciation is provided on straight line method over their useful life. 1??M depreciation is

provided in the year of additions% on additions forming an integral part of existing plans

including incremental cost arising on account of translation of foreign currency liabilities for

accusation of fixed assets. Depreciation is provided as aforesaid over the residual life of the

assets as certifies by values on assets acuired under fianc lease from 1 st #pril 3??1.

Depreciation is provided over the lease term.

g. ,oreign currency transactions&:

)ransactions denominated in foreign currencies are recorded at the exchange rate

prevailing on the date of the transaction.



42/44


!onitory items denominated in foreign currency at year and are restated at year end

rates in case of items which are covered by forward exchange contracts. Gonmonetary currency items are carried at cost.

h. Inventories&:

+tems of inventories are measured at lower of the cost and net reali*able value after providing

for obsolescence if any. (ost of inventories comprises of cost of purchase% cost of conversion

and other cost incurred in bringing them to their respective present location and condition.

i. Em)loyee 8enefits&:

'hort term employee benefits are recogni*e as an expense at the undiscounted amount

in pal account of the year in which the rendered services is rendered. +n respect of employees stock options the excess of fair price on the date of grant over

the exercise price is recogni*ed as differed compensation cost amorti*ed over the

vesting period.

6. Provision for current differed tax&:

6rovision for tax is made after taking in to consideration benefits admissible under the

provisions of the income tax act 1;91. Differed tax resulting from timing difference between

taxable and accounting income is accounted for using the tax rates and laws that are in acted

as on the balacesheet date.k. Provisions contingent lia8ilities and assts&:

6rovisions involving substantial degree of estimation in measurement are recogni*ed when

there is a present obligation is a result of past events. (ontingent liabilities are not recogni*ed

but are disclosed in the notes. (ontingent assets are neither recogni*ed not disclosed.

"onclusion

•

)he R#G"#S 6ro>ect has documented substantial differences in the treatment of student andfaculty in the (ollege of !edicine. (urrent ob>ectives are to

• 1$ continue with analysis of the data collected% particularly the ethnographic interviews with faculty

and department chairs% and

• 3$ (ontinue to meet with faculty and administration to identify additional strategies for solving the

problems identified.

• )he ultimate goal of the pro>ect is to achieve parity for student and faculty in an environment of

academic excellence.



43/44


ibliograp. :References;

www.google.com

httpTTwww.moneycontrol.comTfinancialsTranbaxylaboratoriesTbalance-sheetTRLURL

www.ranbaxy.com

+nternational Directory of (ompany istories% Eol. 4?. 't. =ames 6ress% 3??2.

• httpTTwww.fundinguniverse.comTcompany-historiesTranbaxy-laboratories-ltd-historyT


http://www.google.com/http://www.fundinguniverse.com/company-histories/ranbaxy-laboratories-ltd-history/http://www.google.com/http://www.fundinguniverse.com/company-histories/ranbaxy-laboratories-ltd-history/


44/44


RAnbaxy komal (1).docx

Documents

Transcript of RAnbaxy komal (1).docx